The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

Status:
RECRUITING

Trial end date:
2027-04-01

Target enrollment:

Participant gender:

This study is designed to explore the safety and efficacy for patients with relapsed and/or refractory B-cell lymphoblastic leukemia.

EARLY_PHASE1

Anhui Provincial Hospital